Ironwood Pharmaceuticals IRWD Accounts payable and other current liabilities
Accounts payable and other current liabilities at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's accounts payable and other current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's accounts payable and other current liabilities?
- Ironwood Pharmaceuticals (IRWD) reported accounts payable and other current liabilities of -$4.89M in Q1 2026.
- How has Ironwood Pharmaceuticals's accounts payable and other current liabilities changed year-over-year?
- Ironwood Pharmaceuticals's accounts payable and other current liabilities decreased by 150.6% year-over-year, from $9.66M to -$4.89M.
- What is the long-term trend for Ironwood Pharmaceuticals's accounts payable and other current liabilities?
- Over 2 years (2021 to 2025), Ironwood Pharmaceuticals's accounts payable and other current liabilities has grown at a 57.0% compound annual growth rate (CAGR), from -$2.64M to $6.52M.